What is Souvenaid®?

  • Souvenaid® is a medical nutrition drink that is specially formulated to support memory function in the early stages of Alzheimer’s disease.1
  • Powered by a unique combination of nutrients known as Fortasyn® Connect, formulated to nutritionally support the growth of brain connections.1
  •  Available in 125ml ready-to-drink liquid 
  • 3 delicious flavours available
  • Backed by 20 years of evidence based research*
  • Souvenaid® is proven to slow memory and cognitive decline by an average of 60% in mild cognitive impairment due to Alzheimer's disease when taken daily for 3 years.2-3 Individual results may vary.2-3

 

 

 

Need help finding information?

Caring for someone who is living with early Alzheimer’s disease including mild cognitive impairment brings up a lot of questions. Find out how and where to buy Souvenaid® or learn more about it. Ask their healthcare professional for a recommendation before you buy. 

Hear our real-life success stories

Bill’s story is truly inspiring. Learn about the lifestyle changes he’s made since his diagnosis. To see what other patients and carers think about Souvenaid® visit our reviews page.

#Incentive was provided for this testimonial.

 

 

 

 

A word from Gerald Quigley, Community Pharmacist for over 50 years

What can I expect from Souvenaid?

Illustration of a brain
Supports memory function in early Alzheimer's disease when taken daily for at least 6 months.1-3,6
Illustration of a microscope
Backed by 20 years of evidence-based research1-3,6*
Illustration of a neuron
Supported by an ongoing research program1-3,6

Souvenaid® is powered by Fortasyn® Connect, a unique combination of nutrients formulated to support memory function in early Alzheimer’s disease.Explore it's potential in our comprehensive articles. 

 

 

 

 

 

Souvenaid® is a Food for Special Medical Purposes as classified by Food Standards Australia and New Zealand (FSANZ) as Standard 2.9.5. Souvenaid® is prescribed by a treating healthcare professional for the dietary management of early Alzheimer’s Disease/Mild Cognitive Impairment. Souvenaid® does not cure or alleviate Alzheimer’s disease. 

 

The information on this page is not intended to be a substitute for medical advice. Always seek medical advice from a healthcare professional.

*Based on a study published in 2021. Individual results may vary.

 

1 - Soininen H, et al. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer’s disease. Alzheimer’s Dement. 2021;17(1):1-12.

 

2 - Scheltens P, et al. Efficacy of a medical food in mild Alzheimer’s Disease: A randomized controlled trial. Alzheimer’s Dement. 2010; 6:1-10.

 

3 - Scheltens P, et al. Efficacy of Souvenaid® in mild Alzheimer’s Disease: Results from a randomized controlled trial. J. Alzheimer’s Dis. 2012; 31:225-36.

 

4 - Sijben JWC, et al. A multi nutrient concept to enhance synapse formation and function: science behind a medical food for Alzheimer’s disease. OCL. 2011;18:267-70.

 

5 - Dementia Australia. Alzheimer’s Disease. Everything you need to know [Internet]. 2024 [cited 2025 Feb 6]. Available at: https://www.dementia.org.au/about-dementia/alzheimers-disease-everything-you-need-know   

 

6 - Shah RC, et al. The S-Connect study: results from a randomized, controlled trial of Souvenaid® in mild-to-moderate Alzheimer’s disease. Alzheimer’s Res Ther 2013;5(6):59.

x